Search
FDA investigates two serious adverse events associated with ImprimisRx’s compounded curcumin emulsion product for injection
… wo-serious-adverse-events-associated-imprimisrxs-compounded-curcumin-emulsion … Sign up for email alerts on Compounding … 4, 2017 Summary Two patients administered infusions of curcumin (a component of the spice turmeric) compounded with … reactions. The PEG 40 castor oil was a component of a curcumin emulsion product compounded by a pharmacy, …
For Healthcare Professionals | FDA’s Examples of Drugs that Interact with CYP Enzymes and Transporter Systems
… systems (i.e., St. John’s wort (a dietary supplement), curcumin (a supplement), diosmin (a supplement), tobacco … classes, St. John’s wort (a dietary supplement), curcumin (a supplement), diosmin (a supplement), smoking … crizotinib 3A4 moderate inhibitor curcumin BCRP inhibitor cyclosporine …
Compounding Risk Alerts
… adverse events associated with ImprimisRx’s compounded curcumin emulsion product for injection (August 4, 2017) FDA …
FDA to Compounders: Know Your Bulks and Excipients Suppliers
… about serious adverse events associated with a compounded curcumin emulsion which contained an ungraded polyethylene …
Compounding: Inspections, Recalls, and other Actions
… Adverse Events Associated with ImprimisRx’s Compounded Curcumin Emulsion Product for Injection (8/4/2017) 483 Issued …